These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34349450)

  • 1. National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017).
    Bisht A; Marwaha N; Arora S; Patidar GK; Chhabra R
    Asian J Transfus Sci; 2021; 15(1):1-11. PubMed ID: 34349450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-donation telephonic interview of blood donors providing an insight into delayed adverse reactions: First attempt in India.
    Tiwari AK; Aggarwal G; Dara RC; Arora D; Srivastava K; Raina V
    Transfus Apher Sci; 2017 Apr; 56(2):141-146. PubMed ID: 27839968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of blood donation reported to haemovigilance systems: analysis of eleven years of international surveillance.
    Wiersum-Osselton JC; Politis C; Richardson C; Goto N; Grouzi E; Marano G; Land KJ
    Vox Sang; 2021 Jul; 116(6):628-636. PubMed ID: 33278040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasovagal reactions in whole blood and apheresis donors: a cross-sectional study on donor haemovigilance data from 2016 to 2019 in Italy.
    Piccinini V; Marano G; Catalano L; Pati I; Veropalumbo E; de Waure C; Pupella S; De Angelis V
    Blood Transfus; 2022 Jul; 20(4):281-291. PubMed ID: 34694220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge assessment of a donor adverse reaction severity grading tool by the National Blood Donor Vigilance Programme of India.
    Bisht A; Arora S; Patidar G; Marwaha N
    Vox Sang; 2023 Sep; 118(9):721-729. PubMed ID: 37533234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor vigilance data of a blood transfusion service: A multicenter analysis.
    Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
    Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new donor vigilance system in Denmark reveals regional differences in adverse reactions supposedly caused by variation in the registration.
    Mikkelsen C; Paarup HM; Bruun MT; Pedersen LØ; Hasslund S; Larsen R; Aagaard B; Sørensen BS
    Vox Sang; 2022 Mar; 117(3):321-327. PubMed ID: 34523137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
    Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
    Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood donation by elderly repeat blood donors.
    Zeiler T; Lander-Kox J; Alt T
    Transfus Med Hemother; 2014 Jul; 41(4):242-50. PubMed ID: 25254019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds.
    Eder AF; Hillyer CD; Dy BA; Notari EP; Benjamin RJ
    JAMA; 2008 May; 299(19):2279-86. PubMed ID: 18492969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron Store of Repeat Plasma and Platelet Apheresis Donors.
    Pfeiffer H; Hechler J; Zimmermann R; Hackstein H; Achenbach S
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018).
    Orru' S; Poetzsch K; Hoffelner M; Heiden M; Funk MB; Keller-Stanislawski B; Oberle D
    Transfus Med Hemother; 2021 Oct; 48(5):272-283. PubMed ID: 34803571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of immediate adverse effects associated with apheresis donation.
    McLeod BC; Price TH; Owen H; Ciavarella D; Sniecinski I; Randels MJ; Smith JW
    Transfusion; 1998 Oct; 38(10):938-43. PubMed ID: 9767744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First donor haemovigilance system at a national level in China: Establishment and improvement.
    Yang J; Fan D; Xie D; Guo X; Zhu W; He T; Huang X
    Vox Sang; 2023 May; 118(5):357-366. PubMed ID: 36896482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Haemovigilance donors: methods and results].
    Rebibo D; Danic B
    Transfus Clin Biol; 2007 May; 14(1):142-6. PubMed ID: 17513158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a national disaster on blood supply and safety: the September 11 experience.
    Glynn SA; Busch MP; Schreiber GB; Murphy EL; Wright DJ; Tu Y; Kleinman SH;
    JAMA; 2003 May; 289(17):2246-53. PubMed ID: 12734136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of rare, serious donor reactions: International perspective.
    Young P; Crowder L; Steele W; Irving D; Pink J; Kutner JM; Yokoyama APH; Van Buren N; O'Sullivan NW; Sayers M; Alcantara RM; van den Hurk K; Wiersum-Osselton J; Shaz B;
    Transfusion; 2021 Jun; 61(6):1780-1788. PubMed ID: 33665853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
    Py JY; Durieux S; Barnoux M; Sapey T
    Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.